ZimVie Inc

ZimVie Inc (ZIMV) Stock Analysis

$18.990

0.000 (0.00%)At close

Loading chart…
High
19.000
Open
18.990
VWAP
18.99
Vol
653.57K
Mkt Cap
480.01M
Low
18.990
Amount
12.41M
EV/EBITDA, TTM
7.26

ZimVie Inc. is a global life sciences company in the dental market. It develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. It works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems, dental biomaterial products and digital dentistry solutions. The key products in its dental implant systems portfolio consist of TSX Implant System, Tapered Screw-Vent (TSV) Implant System, T3 Pro Implant System, T3 Implant System, OSSEOTITE Implant System, Trabecular Metal Implant System, BellaTek Patient Specific Products, GenTek Restorative Portfolio, and Encode Healing Abutment / Impression System. It markets its products in about 50 countries.

www.zimvie.com/en

Valuation Metrics

The current forward P/E ratio for ZimVie Inc (ZIMV) is 17.35, compared to its 5-year average forward P/E of 17.18.

Forward P/E

Fair
5Y Average P/E
17.18
Current P/E
17.35
Overvalued
24.39
Undervalued
9.97

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
8.25
Current EV/EBITDA
7.26
Overvalued
11.58
Undervalued
4.92

Forward P/S

Fair
5Y Average P/S
0.64
Current P/S
0.79
Overvalued
0.96
Undervalued
0.32

Alphio AI Price Scenarios for ZIMV

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%ZIMV

$6.37

Scenario price

B

Base

Base · 50%ZIMV

$5.50

Scenario price

B

Bear

Bear · 25%ZIMV

$5.29

Scenario price

Whales holding ZIMV

J

J. Goldman & Co., L.P.

+ HoldingZIMV

-3.02%

3M Return

Events Timeline

2025-10-20 (ET)

09:02:26

ZimVie confirms it has finalized its acquisition by ARCHIMED.

2025-10-10 (ET)

09:16:08

ZimVie Shareholders Give Green Light to ARCHIMED Acquisition

2025-07-25 (ET)

08:18:03

ZimVie withdraws guidance amid ARCHIMED transaction

08:07:19

ZimVie will not host withdraws guidance amid ARCHIMED transaction

2025-07-23 (ET)

17:02:29

ZimVie announces exclusive distribution agreement with Osstem Implant in China

Show More Events

News

Show More News

ZIMV FAQ — answered by Alphio AI

ZimVie Inc. is a global life sciences company in the dental market. It develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. It works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems, dental biomaterial products and digital dentistry solutions. The key products in its dental implant systems portfolio consist of TSX Implant System, Tapered Screw-Vent (TSV) Implant System, T3 Pro Implant System, T3 Implant System, OSSEOTITE Implant System, Trabecular Metal Implant System, BellaTek Patient Specific Products, GenTek Restorative Portfolio, and Encode Healing Abutment / Impression System. It markets its products in about 50 countries. It operates in the Healthcare sector (DENTAL EQUIPMENT & SUPPLIES industry).

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started